Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy. 2004

Kira Q Stolen, and Jukka Kemppainen, and Kari K Kalliokoski, and Hannu Karanko, and Jyri Toikka, and Tuula Janatuinen, and Olli T Raitakari, and K E Juhani Airaksinen, and Pirjo Nuutila, and Juhani Knuuti
Turku PET Centre, Turku, Finland.

The aim of this study was to assess the relation between peripheral endothelial function and myocardial perfusion reserve in patients with mild heart failure due to idiopathic dilated cardiomyopathy (IDC). Myocardial perfusion and brachial artery flow mediated dilation (FMD) were measured in 20 clinically stable patients with IDC (New York Heart Association classes I to III, ejection fraction 35 +/- 9%) and 13 apparently healthy subjects who were matched for age and lipid profile. Resting and hyperemic (dipyridamole; 0.56 mg/kg/min) perfusion were measured using oxygen-15-labeled water and positron emission tomography (PET). Perfusion reserve was calculated as the ratio of hyperemic to resting perfusion. FMD was assessed by measuring the change in brachial artery diameter in response to reactive hyperemia. Patients with IDC had lower hyperemic perfusion (1.73 +/- 0.83 vs 3.01 +/- 1.20 ml/min/g, p <0.001) and perfusion reserve (2.01 +/- 0.91 vs 3.08 +/- 1.35, p <0.01) compared with healthy subjects. Brachial artery FMD, however, was not different from that of the healthy subjects. Furthermore, neither hyperemic perfusion nor perfusion reserve was correlated with FMD in the patients with IDC, whereas the healthy subjects demonstrated a positive correlation between FMD and perfusion reserve (r = 0.57; p = 0.04). Thus, abnormal myocardial perfusion characterizes patients with IDC. Myocardial perfusion reserve and peripheral endothelial function do not parallel each other in patients with IDC.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D010104 Oxygen Radioisotopes Unstable isotopes of oxygen that decay or disintegrate emitting radiation. O atoms with atomic weights 13, 14, 15, 19, and 20 are radioactive oxygen isotopes. Radioisotopes, Oxygen
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D001916 Brachial Artery The continuation of the axillary artery; it branches into the radial and ulnar arteries. Arteries, Brachial,Artery, Brachial,Brachial Arteries
D002311 Cardiomyopathy, Dilated A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein. Cardiomyopathy, Congestive,Congestive Cardiomyopathy,Dilated Cardiomyopathy,Cardiomyopathy, Dilated, 1a,Cardiomyopathy, Dilated, Autosomal Recessive,Cardiomyopathy, Dilated, CMD1A,Cardiomyopathy, Dilated, LMNA,Cardiomyopathy, Dilated, With Conduction Defect 1,Cardiomyopathy, Dilated, with Conduction Deffect1,Cardiomyopathy, Familial Idiopathic,Cardiomyopathy, Idiopathic Dilated,Cardiomyopathies, Congestive,Cardiomyopathies, Dilated,Cardiomyopathies, Familial Idiopathic,Cardiomyopathies, Idiopathic Dilated,Congestive Cardiomyopathies,Dilated Cardiomyopathies,Dilated Cardiomyopathies, Idiopathic,Dilated Cardiomyopathy, Idiopathic,Familial Idiopathic Cardiomyopathies,Familial Idiopathic Cardiomyopathy,Idiopathic Cardiomyopathies, Familial,Idiopathic Cardiomyopathy, Familial,Idiopathic Dilated Cardiomyopathies,Idiopathic Dilated Cardiomyopathy
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums

Related Publications

Kira Q Stolen, and Jukka Kemppainen, and Kari K Kalliokoski, and Hannu Karanko, and Jyri Toikka, and Tuula Janatuinen, and Olli T Raitakari, and K E Juhani Airaksinen, and Pirjo Nuutila, and Juhani Knuuti
June 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
Kira Q Stolen, and Jukka Kemppainen, and Kari K Kalliokoski, and Hannu Karanko, and Jyri Toikka, and Tuula Janatuinen, and Olli T Raitakari, and K E Juhani Airaksinen, and Pirjo Nuutila, and Juhani Knuuti
December 2009, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation,
Kira Q Stolen, and Jukka Kemppainen, and Kari K Kalliokoski, and Hannu Karanko, and Jyri Toikka, and Tuula Janatuinen, and Olli T Raitakari, and K E Juhani Airaksinen, and Pirjo Nuutila, and Juhani Knuuti
January 2005, Journal of inherited metabolic disease,
Kira Q Stolen, and Jukka Kemppainen, and Kari K Kalliokoski, and Hannu Karanko, and Jyri Toikka, and Tuula Janatuinen, and Olli T Raitakari, and K E Juhani Airaksinen, and Pirjo Nuutila, and Juhani Knuuti
October 2016, International journal of cardiology,
Kira Q Stolen, and Jukka Kemppainen, and Kari K Kalliokoski, and Hannu Karanko, and Jyri Toikka, and Tuula Janatuinen, and Olli T Raitakari, and K E Juhani Airaksinen, and Pirjo Nuutila, and Juhani Knuuti
December 2007, American journal of physiology. Heart and circulatory physiology,
Kira Q Stolen, and Jukka Kemppainen, and Kari K Kalliokoski, and Hannu Karanko, and Jyri Toikka, and Tuula Janatuinen, and Olli T Raitakari, and K E Juhani Airaksinen, and Pirjo Nuutila, and Juhani Knuuti
January 2000, Journal of the American College of Cardiology,
Kira Q Stolen, and Jukka Kemppainen, and Kari K Kalliokoski, and Hannu Karanko, and Jyri Toikka, and Tuula Janatuinen, and Olli T Raitakari, and K E Juhani Airaksinen, and Pirjo Nuutila, and Juhani Knuuti
March 2007, Heart (British Cardiac Society),
Kira Q Stolen, and Jukka Kemppainen, and Kari K Kalliokoski, and Hannu Karanko, and Jyri Toikka, and Tuula Janatuinen, and Olli T Raitakari, and K E Juhani Airaksinen, and Pirjo Nuutila, and Juhani Knuuti
July 1993, The Journal of clinical investigation,
Kira Q Stolen, and Jukka Kemppainen, and Kari K Kalliokoski, and Hannu Karanko, and Jyri Toikka, and Tuula Janatuinen, and Olli T Raitakari, and K E Juhani Airaksinen, and Pirjo Nuutila, and Juhani Knuuti
September 1997, Danish medical bulletin,
Kira Q Stolen, and Jukka Kemppainen, and Kari K Kalliokoski, and Hannu Karanko, and Jyri Toikka, and Tuula Janatuinen, and Olli T Raitakari, and K E Juhani Airaksinen, and Pirjo Nuutila, and Juhani Knuuti
January 2022, American journal of cardiovascular disease,
Copied contents to your clipboard!